These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9714914

  • 1. A Neu differentiation factor (NDF) domain essential for proliferation and alterations in morphology of colonic epithelial cells in vitro.
    Whoriskey JS, Pekar SK, Elliott GS, Hara S, Liu N, Lenz DM, Zamborelli T, Mayer JP, Tarpley JE, Lacey DL, Ratzkin B, Yoshinaga SK.
    Growth Factors; 1998; 15(4):307-21. PubMed ID: 9714914
    [Abstract] [Full Text] [Related]

  • 2. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells.
    Ram TG, Kokeny KE, Dilts CA, Ethier SP.
    J Cell Physiol; 1995 Jun; 163(3):589-96. PubMed ID: 7775601
    [Abstract] [Full Text] [Related]

  • 3. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes.
    Marikovsky M, Lavi S, Pinkas-Kramarski R, Karunagaran D, Liu N, Wen D, Yarden Y.
    Oncogene; 1995 Apr 06; 10(7):1403-11. PubMed ID: 7731691
    [Abstract] [Full Text] [Related]

  • 4. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
    Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y, Hynes NE.
    Mol Endocrinol; 1995 Jan 06; 9(1):14-23. PubMed ID: 7760847
    [Abstract] [Full Text] [Related]

  • 5. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins.
    Jeschke M, Wels W, Dengler W, Imber R, Stöcklin E, Groner B.
    Int J Cancer; 1995 Mar 03; 60(5):730-9. PubMed ID: 7860149
    [Abstract] [Full Text] [Related]

  • 6. Structural and functional aspects of the multiplicity of Neu differentiation factors.
    Wen D, Suggs SV, Karunagaran D, Liu N, Cupples RL, Luo Y, Janssen AM, Ben-Baruch N, Trollinger DB, Jacobsen VL.
    Mol Cell Biol; 1994 Mar 03; 14(3):1909-19. PubMed ID: 7509448
    [Abstract] [Full Text] [Related]

  • 7. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.
    Chen X, Levkowitz G, Tzahar E, Karunagaran D, Lavi S, Ben-Baruch N, Leitner O, Ratzkin BJ, Bacus SS, Yarden Y.
    J Biol Chem; 1996 Mar 29; 271(13):7620-9. PubMed ID: 8631797
    [Abstract] [Full Text] [Related]

  • 8. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.
    Tzahar E, Levkowitz G, Karunagaran D, Yi L, Peles E, Lavi S, Chang D, Liu N, Yayon A, Wen D.
    J Biol Chem; 1994 Oct 07; 269(40):25226-33. PubMed ID: 7929212
    [Abstract] [Full Text] [Related]

  • 9. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC, Melhem MF, Finley GG, Wen D, Liu N, Deng DH, Salup R.
    Cancer J Sci Am; 1997 Oct 07; 3(1):21-30. PubMed ID: 9072304
    [Abstract] [Full Text] [Related]

  • 10. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.
    Beerli RR, Hynes NE.
    J Biol Chem; 1996 Mar 15; 271(11):6071-6. PubMed ID: 8626392
    [Abstract] [Full Text] [Related]

  • 11. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit.
    Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Luo Y, Trail G, Hu S, Silbiger SM, Levy RB.
    Cell; 1992 May 01; 69(3):559-72. PubMed ID: 1349853
    [Abstract] [Full Text] [Related]

  • 12. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ.
    Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997
    [Abstract] [Full Text] [Related]

  • 13. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.
    Beerli RR, Graus-Porta D, Woods-Cook K, Chen X, Yarden Y, Hynes NE.
    Mol Cell Biol; 1995 Dec 27; 15(12):6496-505. PubMed ID: 8524214
    [Abstract] [Full Text] [Related]

  • 14. Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds.
    Danilenko DM, Ring BD, Lu JZ, Tarpley JE, Chang D, Liu N, Wen D, Pierce GF.
    J Clin Invest; 1995 Feb 27; 95(2):842-51. PubMed ID: 7860768
    [Abstract] [Full Text] [Related]

  • 15. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
    Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R.
    Cancer Res; 1993 Nov 01; 53(21):5251-61. PubMed ID: 8106145
    [Abstract] [Full Text] [Related]

  • 16. Heregulins or neu differentiation factors and the interactions between peritubular myoid cells and Sertoli cells.
    Hoeben E, Swinnen JV, Heyns W, Verhoeven G.
    Endocrinology; 1999 May 01; 140(5):2216-23. PubMed ID: 10218974
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.